Answers are grounded in this paper and cite their sources.
Introduction: Kidney transplantation is well established as the treatment of choice for end-stage renal disease (ESRD) patients, offering more remarkable survivability and quality of life. Due to the shortage of organs and rising demand, the use of marginal donors has increased in transplant centers. Herein, we report our experience with two renal transplants from a donor with polycystic kidney disease with normal kidney function.
No takes yet. Share an insight, caveat, or question.
El-hinnawi et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: